[Intravenous Subnarcotic Ketamine Infusions for Treatment-Resistant Depression: Historical Development, Comparison with Esketamine Nasalspray, and Prospects].
Udo Bonnet, Norbert Scherbaum, Georg Juckel, Tom Bschor
Fortschr Neurol Psychiatr June 8, 2026 DOI: 10.1055/a-2846-4275 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Depression Esketamine Ketamine |
| Key findings | Intravenous subnarcotic ketamine infusions are effective for treatment-resistant depression, and comparison with esketamine nasal spray reveals differences in administration and potential efficacy. |
Abstract
[Intravenous Subnarcotic Ketamine Infusions for Treatment-Resistant Depression: Historical Development, Comparison with Esketamine Nasalspray, and Prospects].